FXN and Friedreich ataxia: A number of treatment options are being explored for FRDA patients, with some attempting to restore basal levels of frataxin by blocking its ubiquitination and degradation [112], while others are aimed at negating the secondary effects of frataxin deficiency, such as iron chelators and antioxidants [113].